EVFM Evofem Biosciences Inc

Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

As of 10/25/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/20/2014
Outstanding shares:  155,208,456
Average volume:  2,300,723
Market cap:   $110,104,879
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30048L104
ISIN:        US30048L1044
Valuation   (See tab for details)
PE ratio:   -0.72
PB ratio:   12.03
PS ratio:   32.31
Return on equity:   -1,674.19%
Net income %:   -4,403.58%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy